Caribou Biosciences (NASDAQ:CRBU) Announces Earnings Results, Beats Estimates By $0.04 EPS

Caribou Biosciences (NASDAQ:CRBU – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.42) EPS for the quarter, topping the consensus estimate of ($0.46) by $0.04, Yahoo Finance reports. Caribou Biosciences had a negative net margin of 345.05% and a negative return on equity of 33.42%. The business had revenue of […]

Leave a Reply

Your email address will not be published.

Previous post ESSA Pharma (NASDAQ:EPIX) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPS
Next post Kingswood Wealth Advisors LLC Has $305,000 Position in First Trust NASDAQ Rising Dividend Achievers (NASDAQ:RDVY)